vTv Therapeutics (VTVT) Invested Capital (2014 - 2017)
vTv Therapeutics (VTVT) reported Invested Capital of $20.0 million for Q1 2017, up 60.0% sequentially from $12.5 million in Q4 2016.
vTv Therapeutics (VTVT) Invested Capital (2014 - 2017) Analysis & Trends
vTv Therapeutics (VTVT) has 4 years of Invested Capital data on file, last reported at $20.0 million in Q1 2017.
- For the quarter ending Q1 2017, Invested Capital changed N/A year-over-year to $20.0 million; the trailing twelve-month figure through Dec 2017 stood at $20.0 million (up 60.0% YoY), and the FY2016 full-year result was $12.5 million, changed N/A from the prior year.
- Invested Capital improved to $20.0 million in Q1 2017, from $12.5 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $46.6 million in Q2 2015 to a low of $155000.0 in Q4 2014.
- A 4-year average of $19.8 million and a median of $16.2 million in 2016 frame the typical range for Invested Capital.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 110.96 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 116.14 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | vTv Therapeutics | 19.21 Mn | 19.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 20.00 Mn |
| Dec 31, 2016 | 12.50 Mn |
| Jun 30, 2015 | 46.59 Mn |
| Dec 31, 2014 | 155,000.00 |